Victory Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $35.8K | Sell |
|
|||||
|
2024
Q3 | $62.7K | Sell |
|
|||||
|
2024
Q2 | $31.6K | Buy |
|
|||||
|
2024
Q1 | $51.2K | Sell |
|
|||||
|
2023
Q4 | $92.8K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $14.3M | Sell |
|
|||||
|
2023
Q1 | $19.3M | Buy |
|
|||||
|
2022
Q4 | $575K | Sell |
|
|||||
|
2022
Q3 | $1.09M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $264K | Sell |
|
|||||
|
2021
Q2 | $294K | Sell |
|
|||||
|
2021
Q1 | $285K | Buy |
|
|||||
|
2020
Q4 | $278K | Buy |
|
|||||
|
2020
Q3 | $235K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $236K | Buy |
|
|||||
|
2019
Q4 | $160K | Buy |
|
|||||
|
2019
Q3 | $82K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.63M | Sell |
|
|||||
|
2018
Q1 | $1.93M | Buy |
|
|||||
|
2017
Q4 | $1.99M | Buy |
|
|||||
|
2017
Q3 | $956K | Sell |
|
|||||
|
2017
Q2 | $921K | Sell |
|
|||||
|
2017
Q1 | $739K | Buy |
|